Sep 03, 2009|3 min readBy Lori LeskoSanofi’s booster shotSanofi Pasteur strengthens vaccines position in India through control of Shantha Biotechnics
Jul 07, 2020|2 min readBy DDNews StaffSanofi gains access to complementary oncology candidateKiadis licenses previously undisclosed preclinical K-NK-cell programs to Sanofi that could be a first-in-class treatment in multiple myeloma
Tools & Techniques NewsJan 26, 2021|3 min readBy Mel J. YeatesJameel Clinic teams up with Sanofi on AI and machine learningThe collaboration will develop and apply deep learning and machine learning for drug discovery
Tools & Techniques NewsMar 25, 2021|3 min readBy Jennifer CliffordNew support for customized exosomesCiloa’s therapeutic protein platform recognized by Sanofi award program
May 13, 2015|2 min readBy Kelsey KaustinenSanofi, Selecta expand collaborationSanofi has exercised its license option for the development of an immunotherapy for celiac disease
Aug 27, 2020|3 min readBy Kelsey KaustinenA (natural) killer matchKiadis, Sanofi ink license agreement for natural killer therapeutics
Nov 28, 2012|2 min readBy Kelsey KaustinenSelecta signs with SanofiCompanies collaborate to target up to three immunotherapies for allergy suppression
Sep 12, 2012|2 min readBy Kelsey KaustinenOncodesign announces Sanofi collaborationCompanies to identify kinase inhibitors with Oncodesign’s Nanocyclix platform
Apr 09, 2012|4 min readBy Amy SwindermanSanofi cultivates 'research ecosystem'Pharma partners with Spain’s Centre for Genomic Regulation to explore potential of translational medicine
Oct 09, 2016|4 min readBy Jeffrey BouleySanofi shines in diabetes and dermatologyRecent study results for Toujeo and Dupixent mark two clinical trial successes this fall